ex vivo expanded autologous human corneal epithelial cells containing stem cells
Cell therapyexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2018 (NCT03302273)
Timeline
No events for the selected filters.
Mechanism of action
- Unspecified targetOTHER
Somatic cell supplemental therapy
Autologous corneal epithelial cells
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5315099 ↗
Also known as
- ex vivo expanded autologous human corneal epithelial cells containing stem cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03302273 | N/A | Nov 1, 2018 | Panhandle Eye Group, LLP |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Panhandle Eye Group, LLP | Academic/Hospital | 1 | 1 | 1 | 2018 |
1 organizations
Page 1 / 1